Haisco Pharmaceutical Group dividend and valuation

002653 · SZSE · CNY

Compare Haisco Pharmaceutical Group
¥52.48Change from previous close: −2.13%Absolute change: −¥1.14

Close · November 20, 2026

Valuation

Haisco Pharmaceutical Group paid ¥0.79 per share in dividends over the last 12 months (yield 1.5%). Last ex-dividend date: September 4, 2026. The P/E ratio is 44.1. The average price target of 2 analysts is ¥88.47.

Data as of November 21, 2026

Haisco Pharmaceutical Group compared with similar companies

Haisco Pharmaceutical Group's P/E (trailing 12 months): 44.1, +6% against the median of a group of 8 similar companies (41.7).

Haisco Pharmaceutical Group's metrics compared with similar companies
MetricHaisco Pharmaceutical GroupMedian25th–75th percentileBand
P/E (trailing 12 months)44.141.733.9 – 93.5Middle
Forward P/E38.031.720.4 – 43.6Middle
EV/EBITDA37.937.918.2 – 67.6Middle
Price/book9.995.242.69 – 8.16High
Price/sales9.888.894.67 – 31.6Middle
Gross margin77.3%74.6%49.8% – 79.1%Middle
Operating margin21.1%14.9%6.8% – 30.3%Middle
Net margin21.5%7.8%5.4% – 21.4%High
ROE25.6%10.4%5.0% – 19.8%High
Debt/equity0.380.110.05 – 0.40Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Haisco Pharmaceutical Group: valuation over time

On the latest fiscal year's earnings (2025), Haisco Pharmaceutical Group's P/E today is 228.2, above the median of its last 10 fiscal years (57.7; between 29.7 and 223.1 from 2016 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (1.5%) is above the median of the last 9 fiscal years (1.2%).

Haisco Pharmaceutical Group P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
2025¥51.32¥0.23223.1¥0.270.5%
2024¥33.25¥0.3595.0¥0.421.2%
2023¥23.15¥0.2785.7¥0.200.9%
2022¥22.25¥0.2685.6——
2021¥20.40¥0.3263.7¥0.190.9%
2020¥17.52¥0.5929.7¥0.372.1%
2019¥20.36¥0.4644.3¥0.090.5%
2018¥11.89¥0.3138.4¥0.191.6%
2017¥11.37¥0.2251.7¥0.282.5%
2016¥15.63¥0.4138.1¥0.462.9%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
¥59.87B
Enterprise value
¥59.02B
EV/revenue
9.74

Profitability and growth

ROA
9.8%
ROIC
10.8%
Revenue growth (year over year)
44.3%
Earnings growth (year over year)
203.2%

Financial health

Total cash
¥2.75B
Total debt
¥2.27B
Current ratio
1.94
Quick ratio
1.75
Altman Z-Score
14.2
Piotroski F-Score
8.00

Dividends

Annual dividend per share
¥0.79
Dividend yield
1.5%
Payout ratio
66.6%
Ex-dividend date
September 4, 2026

Analysts and estimates

Average price target
¥88.47
Median price target
¥88.47
High price target
¥96.63
Low price target
¥80.30
Analysts with a price target
2
Forward EPS
¥1.38
EPS estimate, current year
¥1.55

Shares and trading

Beta
-0.08
Average volume
4.55M
Shares outstanding
1.14B
Float
266.87M
Institutional ownership
11.6%
Insider ownership
74.5%